MY

Mamta Yadav

Active Director Director DIN 09303673
DIN 09303673 First appointment Sep 2021 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2021
Shareholding value •••• Premium profile

About Mamta Yadav

Data last updated:

Mamta Yadav is a Director at Glovin Pharma Private Limited (since 2021). The company operates in Chemicals. Glovin Pharma Private Limited reported revenue of ₹2.5 Lakh (FY 2023).

DIN 09303673
Primary Designation Director
Industry Chemicals
First Appointment 02 Sep 2021
Oldest Company Age 5 yrs
Largest company Glovin Pharma Private Limited · ₹2.5 Lakh (FY 2023)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Glovin Pharma Private Limited U24100RJ2021PTC076760
Director02 Sep 20212021₹2.5 Lakh (FY 2023)Active

Board colleagues of Mamta Yadav

NameDINCompanyDesignation
Mahendra Kumar Yadav09303592Glovin Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Glovin Pharma Private Limited
Premium access

Shareholding and investment profile for Mamta Yadav

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mamta Yadav

Mamta Yadav currently holds 1 directorship: Glovin Pharma Private Limited (Director, since 02 Sep 2021, revenue ₹2.5 Lakh (FY 2023)).

Mamta Yadav was first appointed on 02 Sep 2021 as Director at Glovin Pharma Private Limited.

The current boards of Mamta Yadav's companies include Mahendra Kumar Yadav (Glovin Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available